Cme (CME) Receivables (2009 - 2026)

Cme (CME) has reported Receivables for 18 consecutive years, with $753.1 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Receivables rose 12.81% year-over-year to $753.1 million in Q2 2026; TTM through Jun 2026 was $753.1 million, a 12.81% increase from a year earlier, with the FY2025 full-year figure at $639.2 million, up 11.53% from the prior year.
• Receivables was $753.1 million for Q2 2026 at Cme, down from $935.5 million in the prior quarter.
• Over five years, Receivables peaked at $935.5 million in Q1 2026 and troughed at $483.2 million in Q4 2022.
• A 5-year average of $639.5 million and a median of $618.6 million in 2022 frame the typical range for Receivables.
• Across the five-year window, Receivables gained 23.34% in 2022 and fell 13.18% in 2024, its largest moves.
• Over 5 years, Receivables stood at $483.2 million in 2022, then rose by 10.84% to $535.6 million in 2023, then increased by 7.0% to $573.1 million in 2024, then rose by 11.53% to $639.2 million in 2025, then advanced by 17.82% to $753.1 million in 2026.
• The last three Receivables figures came in at $753.1 million (Q2 2026), $935.5 million (Q1 2026), and $639.2 million (Q4 2025), per Business Quant data.